Off the Clot Human Serum, Delipidized【SP2010】10 mL 25 mL 50 mL 100 mL 300 mL 1L
如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: Off the Clot Human Serum, Delipidized【SP2010】10 mL 25 mL 50 mL 100 mL 300 mL 1L
產(chǎn)品型號(hào): SP2010
產(chǎn)品展商: 其他品牌
產(chǎn)品文檔: 無(wú)相關(guān)文檔
簡(jiǎn)單介紹
Off the Clot Human Serum, Delipidized【SP2010】10 mL 25 mL 50 mL 100 mL 300 mL 1L
Off the Clot Human Serum, Delipidized【SP2010】10 mL 25 mL 50 mL 100 mL 300 mL 1L
的詳細(xì)介紹
Off the Clot Human Serum, Delipidized
Pricing
|
10 mL
|
$85
|
|
25 mL
|
$180
|
|
50 mL
|
$315
|
|
100 mL
|
$360
|
|
300 mL
|
$810
|
|
1L
|
$1080
|
-
Size
Choose an option10 mL25 mL50 mL100 mL300 mL1 L
SKU: SP2010
Product Description
|
Test
|
Specifications
|
Unit Of Mesasure
|
Methodology
|
|
Total Protein
|
5.0 - 6.5
|
g/dL
|
Biuret
|
|
Glucose
|
65 - 105
|
mg/dL
|
Hexokinase
|
|
Sodium
|
131 - 151
|
mmol/L
|
ISE
|
|
Potassium
|
3.5 - 5.5
|
mmol/L
|
ISE
|
|
Chloride
|
85 - 108
|
mmol/L
|
ISE
|
|
Calcium
|
5.0 -10.0
|
mg/dL
|
Arsenazo II
|
|
B.U.N.
|
7 - 14
|
mg/dL
|
Berthelot
|
|
Creatinine
|
0.7 - 1.4
|
mg/dL
|
Jaffe
|
|
Uric Acid
|
2.5 - 4.5
|
mg/dL
|
Uricase/Trinder
|
|
Phosphorus
|
3.0 - 4.0
|
mg/dL
|
Phosphomolybdate
|
|
Cholesterol
|
≤10
|
mg/dL
|
Enzymatic
|
|
Triglycerides
|
≤10
|
mg/dL
|
GPO
|
|
Bioburden
|
<100
|
cfu/mL
|
USP/BAM
|
|
Catalog Number:
|
SP2010
|
|
Preservative:
|
None
|
|
Storage:
|
-20 °C or colder
|
|
Filtration:
|
0.2 μm
|
|
Source
|
Human serum
|
|
Country of origin
|
USA
|
|
Country of manufacture
|
USA
|
Testing
Each unit of serum used in the preparation of this material was tested and found negative for HIV 1/2, HBsAg, HCV, HIV-1 (NAT), HCV (NAT) and RPR by FDA Approved Methods.
Caution
Products are intended for research or manufacturing of non-injectable products only.
The safe and responsible handling of the product(s) listed above us the responsibility of the customer. We accept no liability for injury resulting from their use or handling. The customer assumes responsibility for the proper disposal of all materials in accordance with Federal and State regulation.
